Skip to main content
Journal cover image

A tumor PD-L1-NLRP3 inflammasome signaling axis drives adaptive resistance to anti-PD-1 immunotherapy

Publication ,  Conference
Theivanthiran, B; Evans, K; DeVito, N; Plebanek, M; Sturdivant, M; Holtzhausen, A; Wachsmuth, L; Salama, A; Kang, Y; Hsu, D; Balko, J ...
Published in: JOURNAL FOR IMMUNOTHERAPY OF CANCER
November 6, 2019

Duke Scholars

Published In

JOURNAL FOR IMMUNOTHERAPY OF CANCER

ISSN

2051-1426

Publication Date

November 6, 2019

Volume

7

Publisher

BMC

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Theivanthiran, B., Evans, K., DeVito, N., Plebanek, M., Sturdivant, M., Holtzhausen, A., … Hanks, B. (2019). A tumor PD-L1-NLRP3 inflammasome signaling axis drives adaptive resistance to anti-PD-1 immunotherapy. In JOURNAL FOR IMMUNOTHERAPY OF CANCER (Vol. 7). BMC.
Theivanthiran, Balamayooran, Kathy Evans, Nicholas DeVito, Michael Plebanek, Michael Sturdivant, Alisha Holtzhausen, Luke Wachsmuth, et al. “A tumor PD-L1-NLRP3 inflammasome signaling axis drives adaptive resistance to anti-PD-1 immunotherapy.” In JOURNAL FOR IMMUNOTHERAPY OF CANCER, Vol. 7. BMC, 2019.
Theivanthiran B, Evans K, DeVito N, Plebanek M, Sturdivant M, Holtzhausen A, et al. A tumor PD-L1-NLRP3 inflammasome signaling axis drives adaptive resistance to anti-PD-1 immunotherapy. In: JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMC; 2019.
Theivanthiran, Balamayooran, et al. “A tumor PD-L1-NLRP3 inflammasome signaling axis drives adaptive resistance to anti-PD-1 immunotherapy.” JOURNAL FOR IMMUNOTHERAPY OF CANCER, vol. 7, BMC, 2019.
Theivanthiran B, Evans K, DeVito N, Plebanek M, Sturdivant M, Holtzhausen A, Wachsmuth L, Salama A, Kang Y, Hsu D, Balko J, Johnson D, Starr M, Nixon A, Hanks B. A tumor PD-L1-NLRP3 inflammasome signaling axis drives adaptive resistance to anti-PD-1 immunotherapy. JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMC; 2019.
Journal cover image

Published In

JOURNAL FOR IMMUNOTHERAPY OF CANCER

ISSN

2051-1426

Publication Date

November 6, 2019

Volume

7

Publisher

BMC

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology